Long-Term Survival, Quality Of Life, And Molecular Features Of The Patients With Solid Pseudopapillary Neoplasm Of The Pancreas: A Retrospective Study Of 454 Cases

• Published in: Annals of surgery
• Main Authors: Liu, Qiaofei, Dai, Menghua, Guo, Junchao, Wu, Huanwen, Wang, Weibin, Chen, Ge, Hu, Ya, Han, Xianlin, Xu, Qiang, Zhang, Xiang, Yang, Sen, Zhang, Yalu, Kleeff, Jorg, Liao, Quan, Wu, Wenming, Liang, Zhiyong, Zhang, Taiping, Zhao, Yupei
• Format: Journal Article
• Language: English
• Published: United States 01.12.2023
• DOI: 10.1097/SLA.0000000000005842

To present comprehensive information on the clinicopathological, molecular, survival characteristics, and quality of life (QOL) after surgery for solid pseudopapillary neoplasm (SPN) of the pancreas in a large cohort after long-term follow-up. SPN is a rare tumor with an uncertain malignant potential, and solid information on long-term prognosis and QOL remains limited. All hospitalized patients with SPNs who underwent surgery between 2001 and 2021 at the Peking Union Medical College Hospital were retrospectively reviewed. The clinicopathological characteristics of the patients were retrieved. A cross-sectional telephone questionnaire was administered to inquire about the QOL. Molecular analyses were performed using whole-exome sequencing. Exactly 454 patients with SPN were enrolled, of whom 18.5% were male, and 81.5% were female. The mean patient age was 31±12 years. In total, 61.3% of the patients had no symptoms. The size of the tumors was 5.38±3.70 cm; 83.4% were solid cystic tumors, and 40.1% had calcifications. The proportions of local resection, distal pancreatectomy with or without splenectomy, and pancreaticoduodenectomy with or without pylorus-preservation were 29.7%, 28.9% or 22.9%, and 11% or 6.8%, respectively. Over the years, there has been a significant shift from open to minimally invasive surgery. Among all surgical procedures, pylorus-preserving pancreaticoduodenectomy had the highest incidence of grade 2 to 4 complications (up to 32.3%), compared to 6.7% in distal pancreatectomy (P<0.001). Regarding histopathology, tissue invasion, perineural invasion, cancerous microvascular emboli, lymph node metastasis, and distant metastasis were present in 16.5%, 2.2%, 0.7%, 2.0%, and 3.1% of patients, respectively. Sixty patients were lost to follow-up. Sixteen of the 390 patients who underwent resection (4.1%) experienced local recurrence or distant metastasis after surgery. In total, 361 patients responded to the telephone survey. Nearly 80% of patients claimed their QOL was not significantly affected after surgery; however, the remaining 20% complained of lower QOL during 3-6 years of follow-up after surgery. No clinicopathological factor could reliably predict clinical recurrence or metastasis after resection. A total of 28 driver genes were detected with mutations in at least two tumor samples and the top three frequently mutated genes were CTNNB1, ATRNL1, and MUC16. This study presented the largest cohort of patients with SPN after surgery from a single center and reported the QOL of these patients. SPN is associated with an extremely favorable long-term survival, even in patients with metastasis, and most patients have a good QOL after surgery.